Biosynthetic Pathways and Genetic Regulation in Streptomyces

Streptomyces species are renowned for their capacity to synthesise a vast array of secondary metabolites, including antibiotics, antitumour agents and immunosuppressants. These compounds arise from dedicated biosynthetic pathways encoded by clustered genes whose expression is tightly controlled by a hierarchy of regulatory elements. Primary metabolism supplies the precursors and energy required, while global regulators respond to environmental cues—such as nutrient limitation and stress—to trigger a metabolic switch towards secondary metabolism. At the cluster level, pathway-specific regulators activate or repress transcription of biosynthetic genes, often in response to small-molecule effectors. Advances in genome sequencing and transcriptome profiling have revealed hundreds of cryptic biosynthetic gene clusters in streptomycete genomes. Unravelling the interplay between cluster-situated regulators, global transcription factors and RNA polymerase sigma factors has become central to unlocking silent pathways. Integration of omics data, metabolic modelling and synthetic biology approaches now enables rational manipulation of both regulatory circuits and host chassis to enhance or redirect metabolite flux. This integrated understanding holds promise for the discovery of novel natural products, scalable production of known compounds and the development of next-generation microbial cell factories with optimised output of high-value molecules.

Research from Nature Portfolio

Recent studies have provided nucleotide-resolution maps of transcriptional start sites and translational footprints in Streptomyces coelicolor, illuminating promoter architectures and revealing widespread leaderless mRNAs. Ribosome profiling demonstrated that translation efficiency of secondary metabolic genes is inversely correlated with their transcription levels, and that key antibiotic regulators are translationally induced at the transition phase. This dual transcriptome–translatome analysis has elucidated how promoter structure, sigma factor selection and translational control converge to orchestrate the metabolic switch from growth to antibiotic production, offering new targets for pathway activation and synthetic promoter design.

Biosynthetic Pathways and Genetic Regulation in Streptomyces publication trend

The graph below shows the total number of articles in biosynthetic pathways and genetic regulation in streptomyces across all publications each year (not limited to Nature Index journals).

Technical terms

Secondary metabolites: Low-molecular-weight compounds not essential for growth but often conferring ecological advantages, including antibiotics and pigments.

Biosynthetic gene cluster: A contiguous set of genes encoding enzymes, regulators and transporters required for the production of a specific secondary metabolite.

Cluster-situated regulator (CSR): A transcriptional activator or repressor encoded within a biosynthetic gene cluster that directly controls expression of pathway genes.

Global regulator: A transcription factor or sigma factor that modulates multiple pathways, linking environmental or developmental signals to broad metabolic responses.

Independent component analysis (ICA): A computational method that decomposes transcriptomic data into statistically independent modules of co-regulated genes (iModulons).

Leaderless mRNA: A transcript lacking a 5′ untranslated region, initiating directly at the start codon, often subject to distinct translational regulation.

Heterologous expression: Production of genes or gene clusters from one organism in a different microbial host to enable metabolite synthesis under controlled conditions.

References

1. Machine‐Learning Analysis of Streptomyces coelicolor Transcriptomes Reveals a Transcription Regulatory Network Encompassing Biosynthetic Gene Clusters. Advanced Science (2024).
2. Multicopy Chromosome Integration and Deletion of Negative Global Regulators Significantly Increased the Heterologous Production of Aborycin in Streptomyces coelicolor. Marine Drugs (2023).
3. The dynamic transcriptional and translational landscape of the model antibiotic producer Streptomyces coelicolor A3(2). Nature Communications (2016).
4. The dynamic architecture of the metabolic switch in Streptomyces coelicolor. BMC Genomics (2010).
5. Engineering of Streptomyces lividans for heterologous expression of secondary metabolite gene clusters. Microbial Cell Factories (2020).
6. Metabolic modeling and analysis of the metabolic switch in Streptomyces coelicolor. BMC Genomics (2010).